Sign in

You're signed outSign in or to get full access.

Aon (AON)

--

Recent press releases and 8-K filings for AON.

Aon reports Q4 2025 results
AON
Earnings
Guidance Update
Share Buyback
  • Q4 adjusted operating income rose 11% to $1.5 billion, with margins expanding 220 bps to 35.5% (FY 2025 margin 32.4%, +90 bps).
  • Generated $1.3 billion in Q4 free cash flow; full-year free cash flow was $3.2 billion (+14%), debt paid down ~$1.9 billion lowering leverage to 2.9×, and returned $1.6 billion to shareholders (including $1 billion in buybacks).
  • 2026 guidance targets mid-single-digit organic revenue growth, 70–80 bps of margin expansion, double-digit free cash flow growth to $4.3 billion, and at least $1 billion in share repurchases.
5 days ago
Aon reports Q4 2025 results
AON
Earnings
Guidance Update
Share Buyback
  • Q4 total revenue of $4.3 B, up 4% Y/Y; organic revenue growth of 5% in Q4 and 6% for FY 2025.
  • Adjusted operating income of $1.525 B with margin expansion of 220 bps to 35.5%; adjusted EPS of $4.85, up 10% Y/Y.
  • Free cash flow of $1.323 B, up 16% Y/Y; returned $160 M in dividends and $250 M in share repurchases in Q4.
  • 2026 guidance targets mid-single-digit organic revenue growth, 70–80 bps of margin expansion, strong EPS growth, and double-digit free cash flow growth.
5 days ago
Aon reports Q4 and FY2025 results and 2026 outlook
AON
Earnings
Guidance Update
Share Buyback
  • Aon delivered FY2025 organic revenue growth of 6%, total revenue of $17 billion (+9%), adjusted operating margin of 32.4% (+90 bps), adjusted EPS of $17.07 (+9%), and free cash flow growth of 14%.
  • In Q4 2025, organic revenue rose 5%, total revenue reached $4.3 billion (+4%), adjusted operating margin expanded to 35.5% (+220 bps), adjusted EPS was $4.85 (+10%), and free cash flow grew 16%.
  • Aon ended 2025 with $7 billion of available capital for 2026, plans at least $1 billion in share repurchases, and will pursue high-return M&A while maintaining investment and dividend discipline.
  • For 2026, the company targets mid-single-digit or greater organic revenue growth, 70–80 bps of adjusted operating margin expansion, strong EPS growth, and double-digit free cash flow, with $4.3 billion expected free cash flow generation.
5 days ago
Aon reports Q4 2025 results
AON
Earnings
Guidance Update
Share Buyback
  • Full-year 2025: organic revenue growth of 6%, total revenue of $17 billion, adjusted operating margin of 32.4% (+90 bps), adjusted EPS of $17.07 (+9%), and free cash flow of $3.2 billion (+14%).
  • Q4 2025: organic revenue growth of 5%, revenue of $4.3 billion (+4%), adjusted operating margin of 35.5% (+220 bps), adjusted EPS of $4.85 (+10%), and free cash flow of $1.3 billion (+16%).
  • Executing on Aon United and the 3×3 plan, with strategic innovation in Alternative Business Services (ABS), data center lifecycle insurance (DCLP), and AI-powered risk solutions, driving client wins and middle-market expansion.
  • 2026 guidance: mid-single-digit organic revenue growth, 70–80 bps of adjusted operating margin expansion, strong adjusted EPS growth, and double-digit free cash flow growth; plans at least $1 billion in share repurchases and retains $7 billion of available capital.
5 days ago
Aon reports Q4 and full-year 2025 results
AON
Earnings
Guidance Update
  • Aon delivered $4.3 billion revenue (+4% YoY) in Q4 and $17.2 billion (+9% YoY) for FY 2025, with organic revenue growth of 5% in Q4 and 6% for the year.
  • Q4 diluted EPS of $7.82 (+138%) and adjusted EPS of $4.85 (+10%), and full-year diluted EPS of $17.02 (+36%) and adjusted EPS of $17.07 (+9%).
  • Strong cash generation: Q4 free cash flow of $1.323 billion (+16%), full-year $3.218 billion (+14%), and $1.9 billion of debt repaid in 2025, achieving the leverage objective in Q4.
  • For 2026, Aon expects mid-single-digit organic revenue growth, 70–80 bps of adjusted operating margin expansion, strong adjusted EPS growth, and double-digit free cash flow growth.
5 days ago
Aon reports fourth-quarter and full-year 2025 results
AON
Earnings
Guidance Update
Share Buyback
  • Aon’s fourth-quarter revenue rose 4% to $4.3 billion, driven by 5% organic growth, while full-year revenue increased 9% to $17.2 billion with 6% organic growth.
  • Diluted EPS in Q4 was $7.82, up 138%, and adjusted EPS was $4.85, up 10%; for the full year, diluted EPS was $17.02, up 36%, and adjusted EPS was $17.07, up 9%.
  • Free cash flow reached $1.32 billion in Q4 (+16%) and $3.22 billion for the year (+14%); the company paid down $1.9 billion of debt and met its leverage target in Q4.
  • Aon introduced 2026 guidance calling for mid-single-digit organic revenue growth, 70–80 bps of adjusted operating margin expansion, strong adjusted EPS growth and double-digit free cash flow growth.
  • The company repurchased 2.7 million shares for $1 billion in 2025 (including 0.7 million shares for $250 million in Q4) and has $1.3 billion of repurchase authorization remaining.
5 days ago
Aon reports severe convective storms as costliest insured peril
AON
  • Aon’s 2026 Climate and Catastrophe Insight report finds that severe convective storms (SCS) have overtaken tropical cyclones as the costliest insured peril of the 21st century, generating $61 billion in insured losses in 2025—the third-highest SCS toll on record.
  • Global economic losses from natural disasters in 2025 amounted to $260 billion (the lowest since 2015), while insured losses remained elevated at $127 billion, marking the sixth consecutive year above the $100 billion threshold.
  • Insurers covered 49% of global economic losses in 2025, leaving a protection gap of 51%, the smallest on record.
  • California wildfires (Palisades and Eaton Fires) were the costliest ever, causing $58 billion in economic losses and $41 billion in insured losses.
Jan 20, 2026, 2:00 PM
Aon Global Limited to redeem and delist 2.875% Senior Notes due 2026
AON
Debt Issuance
Delisting/Listing Issues
  • Aon Global Limited will redeem in full and delist its 2.875% Senior Notes due 2026 from the NYSE on February 14, 2026, at a redemption price of 100% plus accrued interest.
  • The redemption will retire all notes issued on May 14, 2014, under the Indenture dated May 24, 2013 (as amended April 1, 2020).
  • The aggregate redemption price is €510,869,863 (approximately €1,021.74 per €1,000 principal), payable upon surrender of the notes.
  • The Bank of New York Mellon (London Branch) will act as paying agent; final interest will be paid as part of the redemption price.
Jan 15, 2026, 9:05 AM
Aon expands Data Center Lifecycle Insurance Program to $2.5 billion
AON
Product Launch
New Projects/Investments
  • Aon has expanded its Data Center Lifecycle Insurance Program (DCLP) by $1 billion, raising total capacity to $2.5 billion to meet growing risk complexity in cloud, AI and digital infrastructure projects.
  • The program unifies construction, cyber, cargo and operational risks into a single, coordinated solution, streamlining capacity for Construction All Risks, Delay in Start-Up and Operational Property Damage/Business Interruption.
  • Key coverages include up to $400 million for cyber and tech E&O, $100 million in third-party liability (ex-U.S.), and $500 million in project cargo insurance, supported by integrated risk engineering and analytics.
Jan 14, 2026, 8:00 AM
Aon unveils GLP-1 study showing cost savings and reduced cancer risk
AON
  • Sustained GLP-1 therapy users saw 6 percentage points lower medical cost growth at 30 months (diabetes) and 9 points lower with ≥80% adherence; weight-loss users had 3 points lower growth at 18 months and 7 points lower with consistent use.
  • Female GLP-1 users experienced ≈50% fewer ovarian cancer cases, ≈14% fewer breast cancer cases, and 47% fewer MACE hospitalizations (≥80% adherence) versus non-users; male users saw a 26% MACE reduction.
  • Aon projects 9.5% U.S. employer healthcare cost growth in 2026; prescription drugs rising 13–15%, with GLP-1s now accounting for ≈20% of drug spend and up 50% in 2025.
  • Analysis covers July 2022–March 2025 claims from over 50 million commercial lives, including 192,000 GLP-1 users, demonstrating both financial and clinical benefits.
Jan 13, 2026, 1:30 PM